Is levofloxacin (a fluoroquinolone antibiotic) effective for treating bacterial otitis media?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Levofloxacin for Bacterial Otitis Media

Levofloxacin is effective for bacterial otitis media, particularly in cases of recurrent or persistent infections, but should not be used as first-line therapy for simple acute otitis media due to antimicrobial stewardship concerns. 1

Efficacy of Levofloxacin in Otitis Media

  • Levofloxacin has demonstrated excellent bacterial eradication rates (88%) in children with recurrent or persistent otitis media, including 84% eradication of S. pneumoniae and 100% eradication of H. influenzae 1, 2
  • In a prospective, open-label study of 205 children (80% under 2 years), levofloxacin was well-tolerated with vomiting (4%) as the most common adverse effect 1, 2
  • Levofloxacin has been shown to be non-inferior to amoxicillin/clavulanate for treatment of recurrent and persistent AOM in infants and children with clinical cure rates of 72.4% vs 69.9% respectively 3

Appropriate Use Guidelines

  • Levofloxacin should not be used as first-line therapy for simple acute bacterial otitis media 1
  • For uncomplicated acute otitis media, amoxicillin remains the first-line drug of choice 4, 5
  • Levofloxacin should be reserved for:
    • Recurrent or persistent otitis media cases 1, 2
    • Cases where first-line treatments have failed 1
    • Patients with allergies to first-line agents 1

Antimicrobial Coverage

  • Levofloxacin has enhanced activity against the common pathogens in otitis media:
    • Streptococcus pneumoniae (including drug-resistant strains) 1
    • Haemophilus influenzae 1, 2
    • Moraxella catarrhalis 1
  • Levofloxacin is particularly effective against fluoroquinolone-susceptible Pseudomonas aeruginosa, which can be present in complicated cases 6

Important Considerations and Cautions

  • The American Academy of Pediatrics recommends limiting fluoroquinolone use to appropriate indications to prevent development of antimicrobial resistance 1
  • The pharmaceutical manufacturer has not sought FDA approval for levofloxacin use in acute bacterial otitis media in children 1
  • French guidelines recommend levofloxacin as a second-line antibiotic for treatment failures or frequent exacerbations, not as first-line therapy 1
  • For children under 2 years with AOM, antibiotic therapy is recommended (Grade A evidence), but fluoroquinolones are not first-line 1

Treatment Algorithm

  1. For simple acute otitis media:

    • First-line: Amoxicillin 4, 5
    • Second-line (for beta-lactamase producing strains): Amoxicillin-clavulanate, cefuroxime-axetil, or other appropriate cephalosporins 1, 4
  2. For recurrent or persistent otitis media:

    • Consider levofloxacin (10 mg/kg twice daily for 10 days) if first-line treatments have failed 1, 2, 3
    • Monitor for adverse effects, with vomiting being the most commonly reported (4% of cases) 1, 2
  3. For complicated cases with suspected Pseudomonas:

    • Levofloxacin may be appropriate based on culture and sensitivity results 6

Remember that overuse of fluoroquinolones can contribute to antimicrobial resistance, so their use should be limited to appropriate clinical scenarios where benefits outweigh risks 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of otitis media.

American family physician, 1992

Research

Current therapy for otitis media and criteria for evaluation of new antimicrobial agents.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992

Research

[Screening for effective antibiotics in chronic suppurative otitis media].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.